Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Guardant Health IncGH-7.845.80-2,495.41-10.11-609.28%-19.64%40.11$29.09$92.8676,656$32.65

Detail of Guardant Health Inc

 
CEO
Dr. Helmy Eltoukhy Ph.D.
Employees
1768
Industry
Diagnostics & Research
Sector
Healthcare
Market cap
$4B

Company details

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$692.26M
Cost of goods (CoG)
-$274.72M
Gross profit (GP)
$417.53M
Operating expense (OE)
-$849.27M
Research and development (R&D)
-$344.07M
General and administrative (G&A)
-$505.21M
Operating income (OI)
-$515.14M
Other income expense (OIE)
-$50.59M
Pretax income (PI)
-$512.38M
Tax (TAX)
-$27,000.00
Net income (NI)
-$512.41M
Guardant Health Inc
GH • XNGS • US
$32.65
+3.15 (10.68%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$4.16
Margin profit
-74.02%
52 week low
$16.07
52 week high
$36.290001
50-day simple moving average
$30.17
200-day simple moving average
$29.09
Percent held by insiders
4.56%
Percent held by institutions
104.61%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
GH +15.82%
eps change
GH 0.00%